Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Erwin

Showing results (131-140 of 154) with videos related to

Pageof 16
Sort By:
The Journal of Antimicrobial Chemotherapy|March 1, 1991
Quality control guidelines for Haemophilus test medium MIC susceptibility tests with cefmetazole, cefpodoxime, CI-960 (PD127391, AM-1090), and RU29246R N Jones, J A Washington, M A Pfaller, et al.
Diagnostic Microbiology and Infectious Disease|February 1, 1992
Interpretive criteria and quality control guidelines for lomefloxacin and meropenem in susceptibility tests of Haemophilus influenzae using Haemophilus test mediumM A Pfaller, R N Jones, J A Washington, et al.
Diagnostic Microbiology and Infectious Disease|September 1, 1992
Cefmetazole and trospectomycin in vitro susceptibility testing interpretive criteria and quality control guidelines for Neisseria gonorrheaeR N Jones, M E Erwin, J A Washington, et al.
Diagnostic Microbiology and Infectious Disease|June 4, 1999
Comparative antimicrobial activity of gatifloxacin tested against Streptococcus spp. including quality control guidelines and etest method validation. Quality Control Study GroupR N Jones, D M Johnson, M E Erwin, et al.
Diagnostic Microbiology and Infectious Disease|March 1, 1993
Multilaboratory evaluation of the in vitro activity of 13 beta-lactam antibiotics against 1474 clinical isolates of aerobic and anaerobic bacteriaP R Murray, R N Jones, S D Allen, et al.
Journal of Clinical Microbiology|May 1, 1992
MIC and disk diffusion quality control guidelines for Neisseria gonorrhoeae susceptibility tests of cefdinir, cefetamet, CI-960, fleroxacin, lomefloxacin, and temafloxacinM E Erwin, R N Jones, F P Koontz, et al.
Journal of Clinical Microbiology|March 1, 1992
Disk diffusion quality control guidelines for Haemophilus susceptibility tests using cefdinir, CI-960, fleroxacin, temafloxacin, and trospectomycinM J Bale, R N Jones, M E Erwin, et al.
The Journal of Antimicrobial Chemotherapy|December 1, 1993
In-vitro comparison of DU-6859a, a novel fluoroquinolone, with other quinolones and oral cephalosporins tested against 5086 recent clinical isolatesS A Marshall, R N Jones, P R Murray, et al.
Journal of Clinical Microbiology|January 1, 1992
MIC quality control guidelines for Haemophilus susceptibility tests using cefdinir (FK482), cefepime, cefetamet, cefpirome, ceftibuten, fleroxacin, temafloxacin, clarithromycin, RP59500, and trospectomycinM J Bale, R N Jones, M E Erwin, et al.
Diagnostic Microbiology and Infectious Disease|August 1, 1993
In vitro activity of cefpodoxime compared with other oral cephalosporins tested against 5556 recent clinical isolates from five medical centersH S Sader, R N Jones, J A Washington, et al.
Pageof 16

Showing results (131-140 of 154) with videos related to

Sort By:
Pageof 16
The Journal of Antimicrobial Chemotherapy|March 1, 1991
Quality control guidelines for Haemophilus test medium MIC susceptibility tests with cefmetazole, cefpodoxime, CI-960 (PD127391, AM-1090), and RU29246R N Jones, J A Washington, M A Pfaller, et al.
Diagnostic Microbiology and Infectious Disease|February 1, 1992
Interpretive criteria and quality control guidelines for lomefloxacin and meropenem in susceptibility tests of Haemophilus influenzae using Haemophilus test mediumM A Pfaller, R N Jones, J A Washington, et al.
Diagnostic Microbiology and Infectious Disease|September 1, 1992
Cefmetazole and trospectomycin in vitro susceptibility testing interpretive criteria and quality control guidelines for Neisseria gonorrheaeR N Jones, M E Erwin, J A Washington, et al.
Diagnostic Microbiology and Infectious Disease|June 4, 1999
Comparative antimicrobial activity of gatifloxacin tested against Streptococcus spp. including quality control guidelines and etest method validation. Quality Control Study GroupR N Jones, D M Johnson, M E Erwin, et al.
Diagnostic Microbiology and Infectious Disease|March 1, 1993
Multilaboratory evaluation of the in vitro activity of 13 beta-lactam antibiotics against 1474 clinical isolates of aerobic and anaerobic bacteriaP R Murray, R N Jones, S D Allen, et al.
Journal of Clinical Microbiology|May 1, 1992
MIC and disk diffusion quality control guidelines for Neisseria gonorrhoeae susceptibility tests of cefdinir, cefetamet, CI-960, fleroxacin, lomefloxacin, and temafloxacinM E Erwin, R N Jones, F P Koontz, et al.
Journal of Clinical Microbiology|March 1, 1992
Disk diffusion quality control guidelines for Haemophilus susceptibility tests using cefdinir, CI-960, fleroxacin, temafloxacin, and trospectomycinM J Bale, R N Jones, M E Erwin, et al.
The Journal of Antimicrobial Chemotherapy|December 1, 1993
In-vitro comparison of DU-6859a, a novel fluoroquinolone, with other quinolones and oral cephalosporins tested against 5086 recent clinical isolatesS A Marshall, R N Jones, P R Murray, et al.
Journal of Clinical Microbiology|January 1, 1992
MIC quality control guidelines for Haemophilus susceptibility tests using cefdinir (FK482), cefepime, cefetamet, cefpirome, ceftibuten, fleroxacin, temafloxacin, clarithromycin, RP59500, and trospectomycinM J Bale, R N Jones, M E Erwin, et al.
Diagnostic Microbiology and Infectious Disease|August 1, 1993
In vitro activity of cefpodoxime compared with other oral cephalosporins tested against 5556 recent clinical isolates from five medical centersH S Sader, R N Jones, J A Washington, et al.
Pageof 16